biotech · ALK-positive Non-small Cell Lung Cancer · Biliary Tract Carcinoma
Zelgen Biopharmaceuticals
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Zelgen Biopharmaceuticals patent portfolio — 0 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- Kunshan, CN
- Employees
- 8
- Programs
- 3
- Drugs
- 7
- Patents
- 0
Zelgen Biopharmaceuticals patents
0 pharmaceutical patents indexed for Zelgen Biopharmaceuticals. 0 expire within 24 months.
Zelgen Biopharmaceuticals has 0 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
No patents matched
Frequently asked questions
How many patents does Zelgen Biopharmaceuticals have?
0 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Zelgen Biopharmaceuticals patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.